Your session is about to expire
← Back to Search
Multidomain Exercise & Cognitive Training for Aging-related Cognitive Decline (ACTIONcR Trial)
N/A
Recruiting
Led By Louis Bherer, PhD
Research Sponsored by Louis Bherer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Normal or corrected vision and normal hearing for their age range
Adult aged 60 and older
Must not have
Severe exercise intolerance
Symptomatic aortic stenosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post-intervention at 12 months.
Awards & highlights
No Placebo-Only Group
Summary
This trial is designed to investigate the effect of different types of exercise on the neurocognitive functioning of sedentary older adults with and without cardiovascular risk factors.
Who is the study for?
This trial is for sedentary adults aged 60 and older who are generally healthy, with no cognitive impairment (scoring at least 25 on the MMSE), and have normal vision and hearing for their age. It's not suitable for those with severe cardiovascular or respiratory diseases, excessive alcohol consumption, certain heart conditions, uncontrolled mental health issues within the past six months, neurological diseases or dementia.
What is being tested?
The ACTIONcardioRisk trial examines if a combination of aerobic exercises, resistance training, and brain exercises can help prevent memory loss in older adults who don't exercise much but may have heart health risks. Participants will be guided through specific physical and cognitive activities.
What are the potential side effects?
While this program focuses on safe exercises and brain games designed to improve health without significant risk, some participants might experience muscle soreness or fatigue due to new physical activities. Cognitive training typically does not cause side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My vision and hearing are normal or corrected to normal for my age.
Select...
I am 60 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot tolerate heavy physical activity.
Select...
I have symptoms from a narrowed heart valve.
Select...
I have long-term heart failure.
Select...
I have atrial fibrillation.
Select...
I have a neurological condition.
Select...
I have a respiratory condition like asthma or COPD.
Select...
I have been diagnosed with atherosclerosis in my brain, limbs, or heart.
Select...
I have dangerous heart rhythms when I exercise.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and post-intervention at 12 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post-intervention at 12 months.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in episodic memory
Change in executive functions
Change in general cognitive functioning
+1 moreSecondary study objectives
Change in brain structure
Change in cerebral activity
Change in cerebral autoregulation - frontal cortical region
+6 moreOther study objectives
Baseline level of physical activity
Change in Balance performance
Change in Dietary patterns
+35 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Physical exercise interventionExperimental Treatment1 Intervention
The physical exercises intervention will include aerobic and resistance exercises training, three sessions per week for 46 weeks. Participants will be allowed to perform cognitive and exercise training sessions either home-based or centre-based.
Group II: Multidomain interventionExperimental Treatment2 Interventions
The multidomain intervention will combine a cognitive training with aerobic and resistance exercises training, three sessions per week for 46 weeks. Participants will be allowed to perform cognitive and exercise training sessions either home-based or centre-based.
Group III: Active control interventionActive Control1 Intervention
The active control intervention will include stretching and toning exercises, three sessions per week for 46 weeks. Participants will be allowed to perform cognitive and exercise training sessions either home-based or centre-based.
Find a Location
Who is running the clinical trial?
Louis BhererLead Sponsor
5 Previous Clinical Trials
272 Total Patients Enrolled
3 Trials studying Aging
178 Patients Enrolled for Aging
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,517,914 Total Patients Enrolled
14 Trials studying Aging
4,433 Patients Enrolled for Aging
The Montreal Health Innovations Coordinating Center (MHICC)OTHER
13 Previous Clinical Trials
10,727 Total Patients Enrolled
1 Trials studying Aging
216 Patients Enrolled for Aging
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My vision and hearing are normal or corrected to normal for my age.I cannot tolerate heavy physical activity.I am 60 years old or older.I have symptoms from a narrowed heart valve.I have long-term heart failure.I have atrial fibrillation.I have a neurological condition.I have a respiratory condition like asthma or COPD.I have been diagnosed with atherosclerosis in my brain, limbs, or heart.I have dangerous heart rhythms when I exercise.
Research Study Groups:
This trial has the following groups:- Group 1: Physical exercise intervention
- Group 2: Active control intervention
- Group 3: Multidomain intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger